published meta-analysis   sensitivity analysis   studies

standard of care in COVID-19 mild to moderate - Summary of results

OutcomeTE95% CInkI2ROBPub. bias clinical improvementdetailed resultsTang, 2020 (REV) 0.99 [0.57; 1.70] 0.99[0.57; 1.70]Tang, 2020 (REV)10%119NAnot evaluable clinical improvement (time to event analysis only)detailed resultsTang, 2020 (REV) 0.99 [0.57; 1.70] 0.99[0.57; 1.70]Tang, 2020 (REV)10%119NAnot evaluable viral clearance detailed resultsTang, 2020 (REV) 1.18 [0.81; 1.72] 1.18[0.81; 1.72]Tang, 2020 (REV)10%150NAnot evaluable viral clearance (time to event analysis only)detailed resultsTang, 2020 (REV) 1.18 [0.81; 1.72] 1.18[0.81; 1.72]Tang, 2020 (REV)10%150NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-05-22 06:53 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 90 - treatments: 651 - roots T: 651